Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
Clinical trial NCT01416831 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01416831
- Sponsor
- Providence Health & Services
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2017-04-05
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.